Online inquiry

IVTScrip™ mRNA-Human ARHGEF3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28616MR)

This product GTTS-WK28616MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGEF3 protein. This product can be used in Ciliated epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001128615.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 50650
UniProt ID Q9NR81
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28616MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK0911MR IVTScrip™ mRNA-Human NOV, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA NOV
GTTS-WK2535MR IVTScrip™ mRNA-Human CD9, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CD9
GTTS-WK19697MR IVTScrip™ mRNA-Human ANKRD10, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD10
GTTS-WK24119MR IVTScrip™ mRNA-Human ARHGEF39, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARHGEF39
GTTS-WK21716MR IVTScrip™ mRNA-Human ARHGEF3, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF3
GTTS-WK28703MR IVTScrip™ mRNA-Human ASCC2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASCC2
GTTS-WK19710MR IVTScrip™ mRNA-Human ANKRD20A9P, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD20A9P
GTTS-WK28327MR IVTScrip™ mRNA-Human ARID5A, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARID5A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →